Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$908M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$706M |
| 3 |
Truist Financial
TFC
|
+$462M |
| 4 |
Amazon
AMZN
|
+$348M |
| 5 |
ServiceNow
NOW
|
+$268M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$130M |
| 5 |
Intuitive Surgical
ISRG
|
+$117M |
Sector Composition
| 1 | Technology | 19.82% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHAS
3176
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.16M | ﹤0.01% |
189,717
+7,371
| +4% | +$45K |
|
|
YELL
3177
DELISTED
Yellow Corporation Common Stock
YELL
| $1.16M | ﹤0.01% |
454,335
+6,244
| +1% | +$15.9K |
|
3178
BioXcel Therapeutics
BTAI
$52.4M
| $1.16M | ﹤0.01% |
4,950
+1,081
| +28% | +$253K |
|
3179
Middlefield Banc Corp
MBCN
$236M
| $1.15M | ﹤0.01% |
44,171
+1
| +0% | +$26 |
|
|
GCAP
3180
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $1.15M | ﹤0.01% |
291,140
+7,878
| +3% | +$31.1K |
|
3181
Spero Therapeutics
SPRO
$111M
| $1.15M | ﹤0.01% |
119,452
+2,670
| +2% | +$25.7K |
|
|
ADMS
3182
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.14M | ﹤0.01% |
300,457
+33,902
| +13% | +$128K |
|
3183
Purple Innovation
PRPL
$114M
| $1.14M | ﹤0.01% |
130,314
+113,100
| +657% | +$985K |
|
3184
Universal Technical Institute
UTI
$1.52B
| $1.13M | ﹤0.01% |
147,180
+27,606
| +23% | +$213K |
|
3185
KB Financial Group
KB
$28.9B
| $1.13M | ﹤0.01% |
27,343
+6,715
| +33% | +$278K |
|
3186
Nova
NVMI
$8.23B
| $1.13M | ﹤0.01% |
29,933
+3,590
| +14% | +$136K |
|
3187
iShares Currency Hedged MSCI EAFE ETF
HEFA
$6.57B
| – | – |
0
| – | -$1.11M |
|
|
GEN
3188
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.13M | ﹤0.01% |
688,297
+23,585
| +4% | +$38.7K |
|
3189
LSI Industries
LYTS
$682M
| $1.13M | ﹤0.01% |
186,079
+1,110
| +0.6% | +$6.71K |
|
3190
Colony Bankcorp
CBAN
$297M
| $1.12M | ﹤0.01% |
68,032
+641
| +1% | +$10.6K |
|
|
GBL
3191
DELISTED
GAMCO Investors, Inc.
GBL
| $1.12M | ﹤0.01% |
57,373
+1,358
| +2% | +$26.5K |
|
3192
Stereotaxis
STXS
$262M
| $1.12M | ﹤0.01% |
+211,184
| New | +$1.12M |
|
3193
LSB Industries
LXU
$569M
| $1.12M | ﹤0.01% |
345,570
+12,507
| +4% | +$40.4K |
|
3194
Maui Land & Pineapple Co
MLP
$336M
| $1.12M | ﹤0.01% |
99,150
+262
| +0.3% | +$2.95K |
|
|
ATCX
3195
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $1.11M | ﹤0.01% |
110,000
+10,000
| +10% | +$101K |
|
3196
Ranpak Holdings
PACK
$407M
| $1.11M | ﹤0.01% |
+136,419
| New | +$1.11M |
|
|
SSI
3197
DELISTED
Stage Stores Inc
SSI
| $1.11M | ﹤0.01% |
136,736
-30,230
| -18% | -$245K |
|
|
ICBK
3198
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $1.1M | ﹤0.01% |
42,938
| – | – |
|
3199
Aclaris Therapeutics
ACRS
$230M
| $1.1M | ﹤0.01% |
581,183
+90,067
| +18% | +$170K |
|
3200
Renovaro
RENB
$51.1M
| $1.09M | ﹤0.01% |
218,036
+162,210
| +291% | +$814K |
|